# FILO (French Innovative Leukemia Organisation)

Source: https://onco.cc/companies/filo/  
OnCo record `filo` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

FILO is the French cooperative group for leukaemia trials, with its registered office in the haematology department of the Tours university hospital; in OnCo it leads a phase 2 trial of eltrombopag in older patients with acute myeloid leukaemia.

## Summary

The French Innovative Leukemia Organisation (FILO) is a French leukaemia cooperative group whose registered office is at the CHU Bretonneau, Centre Henry Kaplan, cellular haematology department, 2 boulevard Tonnellé, Tours (filo-leucemie.org). No founding year is stated on the pages read. ClinicalTrials.gov names it lead sponsor (OTHER class, with Novartis as collaborator) of NCT03603795 (EPAG2015, phase 2, eltrombopag in elderly patients with acute myeloid leukaemia), the trial recorded in OnCo. It has no products of its own.

## Fields

- Kind: Company
- Last checked: 2026-09-25
- Also known as: French Innovative Leukemia Organisation; FILO
- Tags: ctgov-sponsor; cooperative-group
- HQ: Tours
- Type: cooperative-group
- Website: https://www.filo-leucemie.org

## Sources

- Official website: https://www.filo-leucemie.org
- ClinicalTrials.gov: trials led by French Innovative Leukemia Organisation: https://clinicaltrials.gov/search?lead=French%20Innovative%20Leukemia%20Organisation

## Connected records

- cancers: [Acute myeloid leukaemia](https://onco.cc/cancers/aml/)
- trials: [Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy](https://onco.cc/trials/nct03603795/)

---
JSON: https://onco.cc/api/v1/entities/filo.json